Published in Br J Vener Dis on December 01, 1976
Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles. Antimicrob Agents Chemother (1979) 2.53
Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. J Infect Dis (2008) 2.21
How suitable are available pharmaceuticals for the treatment of sexually transmitted diseases? 1: Conditions presenting as genital discharges. Br J Vener Dis (1977) 1.59
Metronidazole-resistant Trichomonas vaginalis. Br J Vener Dis (1979) 1.28
Metronidazole resistance of Trichomonas vaginalis as a cause of treatment failure in trichomoniasis--A case report. Br J Vener Dis (1982) 1.13
Studies on strain sensitivity of Trichomonas vaginalis to metronidazole. Br J Vener Dis (1978) 1.07
Use of a time-kill technique for susceptibility testing of Trichomonas vaginalis. Antimicrob Agents Chemother (1985) 0.92
Persistent Trichomonas vaginalis infection due to a metronidazole-resistant strain. CMAJ (1986) 0.82
Secnidazole. A 5-nitroimidazole derivative with a long half-life. Br J Vener Dis (1978) 0.79
[The activity of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (R. P. 8823) against experimental Trichomonas vaginalis infections]. Ann Inst Pasteur (Paris) (1959) 12.23
Absorption and excretion of metronidazole. I. Serum concentration and urinary excretion after oral administration. Br J Vener Dis (1961) 7.56
Strain sensitivity of Trichomonas vaginalis to metronidazole. Br J Vener Dis (1962) 5.34
Laboratory studies with the systemic trichomonacide, metronidazole. J Clin Pathol (1961) 3.98
The antitrichomonal activity of amidonitrothiazoles. J Pharm Pharmacol (1955) 3.19
Trichomonal vaginitis treated with one dose of metronidazole. Br J Vener Dis (1971) 2.81
Further observations on strain sensitivity of Trichomonas vaginalis to metronidazole. Br J Vener Dis (1969) 2.46
Trichomoniasis in a closed community: efficacy of metronidazole. Br Med J (1971) 2.15
Metronidazole treatment of trichomoniasis in the female. Report of an extended trial. Br Med J (1962) 1.87
Tinidazole, a new antiprotozoal agent: Effect on Trichomonas and other protozoa. Antimicrob Agents Chemother (Bethesda) (1969) 1.71
Effects of l-(2-nitro-l-imidazolyl)-3-methoxy-2-propanol and 2-methyl-5-nitroimidazole-l-ethanol against anaerobic and aerobic bacteria and protozoa. Appl Microbiol (1969) 1.68
Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses. Br J Vener Dis (1975) 1.41
Tinidazole and metronidazole pharmocokinetics in man and mouse. Antimicrob Agents Chemother (Bethesda) (1969) 1.41
Influence of normal human serum on the determination of trichomonicidal drug concentrations. Br J Vener Dis (1972) 1.35
Metronidazole treatment of trichomonal vaginitis. A comparison of cure rates in 1961 and 1967. Acta Obstet Gynecol Scand (1969) 1.23
Induction of in-vivo resistance of trichomonas vaginalis to metronidazole. Lancet (1969) 1.06
[Observations and problems in the treatment of trichomonas vaginitis]. Ther Umsch (1966) 1.04
[Nitrimidazone, a new systemic trichomonacide]. G Mal Infett Parassit (1969) 0.90
Sensitivity of Trichomonas vaginalis to chemotherapeutic agents. J Obstet Gynaecol Br Commonw (1973) 0.86
Metronidazole and nitrimidazine. Lancet (1972) 0.85
[BIOLOGICAL PROPERTIES OF N-(5-NITRO-2-FURFURYLIDENE)-3-AMINO-5-METHYLMERCAPTOMETHYL-2-OXAZOLIDINONE]. Farmaco Sci (1964) 0.80
[The antibicrobical action of new aminoguanidones]. Zentralbl Bakteriol Orig (1969) 0.80
Experimental models for the evaluation of systemic trichomonacides. Models for evaluation of trichomonacides. Chemotherapy (1973) 0.80
[Diagnosis of trichomonas infections. Comparison between methods]. Ugeskr Laeger (1973) 0.79
[Improvement of culture media of Trichomonas for rapid diagnosis]. Can J Public Health (1968) 0.79
Streptococcus pneumoniae infections of the female genital tract and in the newborn child. Rev Infect Dis (1990) 1.96
Incidence of Candida albicans in women using oral contraceptives. Acta Obstet Gynecol Scand (1970) 1.66
Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis. Scand J Gastroenterol (1976) 1.54
Four-strand hamstring tendon autograft compared with patellar tendon-bone autograft for anterior cruciate ligament reconstruction. A randomized study with two-year follow-up. Am J Sports Med (2001) 1.54
Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections. Chemotherapy (1974) 1.41
Human thymidine kinase 1. Regulation in normal and malignant cells. Adv Enzyme Regul (1995) 1.31
In vitro antimicrobial susceptibility of Aerococcus urinae to 14 antibiotics, and time-kill curves for penicillin, gentamicin and vancomycin. J Antimicrob Chemother (2001) 1.29
Aerococcus-like organism, a newly recognized potential urinary tract pathogen. J Clin Microbiol (1991) 1.23
Yersinia enterocolitica infection in patients with acute surgical abdominal disease. A prospective study. Scand J Infect Dis (1976) 1.17
Susceptibility testing of Danish isolates of Capnocytophaga and CDC group DF-2 bacteria. APMIS (1989) 1.15
[Single-dose treatment with ornidazole (Tiberal) and 7 days treatment with metronidazole (Flagyl) for vaginal trichomoniasis. A controlled study in general practice]. Ugeskr Laeger (1977) 1.04
Impact of acute biventricular pacing on left ventricular performance and volumes in patients with severe heart failure. A tissue doppler and three-dimensional echocardiographic study. Cardiology (2001) 1.02
Aerococcus-like organism--an unnoticed urinary tract pathogen. APMIS (1989) 1.02
Bacteremia/septicemia due to Aerococcus-like organisms: report of seventeen cases. Danish ALO Study Group. Clin Infect Dis (1995) 0.98
Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma. Br J Cancer (2010) 0.98
Patients' attitudes toward detection of heterozygous familial hypercholesterolemia. Arch Intern Med (1997) 0.96
Urosepticemia and fatal endocarditis caused by aerococcus-like organisms. Scand J Infect Dis (1991) 0.94
Topical ampicillin against wound infection after colorectal surgery. Ann Surg (1972) 0.93
Fulminant septicemia caused by Yersinia enterocolitica. Scand J Infect Dis (1977) 0.93
Incidence of the apolipoprotein B-3500 mutation in Denmark. Clin Chim Acta (1994) 0.92
An endemic caused by multiresistant klebsiella in an urological unit. Scand J Urol Nephrol (1972) 0.91
Bacteremia in cirrhosis of the liver. Liver (1986) 0.90
Aerococcus-like organisms: use of antibiograms for diagnostic and taxonomic purposes. J Antimicrob Chemother (1996) 0.90
Trimethoprim resistance in Finland. Br Med J (1980) 0.89
Three dimensional echocardiography documents haemodynamic improvement by biventricular pacing in patients with severe heart failure. Heart (2001) 0.87
Gentamicin therapy administered by intermittent intravenous injections. Acta Pathol Microbiol Scand B Microbiol Immunol (1973) 0.87
Survey radiography of abdomen following caesarean section, with particular reference to caecal diameter and the presence of free subdiaphragmatic gas. Acta Obstet Gynecol Scand (1976) 0.86
Protein expression studies of desmoplakin mutations in cardiomyopathy patients reveal different molecular disease mechanisms. Clin Genet (2012) 0.84
Identification of recurrent and novel mutations in the LDL receptor gene in Spanish patients with familial hypercholesterolemia. Mutations in brief no. 135. Online. Hum Mutat (1998) 0.83
Aerococcus urinae: polyphasic characterization of the species. APMIS (2005) 0.83
Functional characterization of two low density lipoprotein receptor gene mutations by fluorescence flow cytometric assessment of receptor activity in stimulated human T-lymphocytes. Clin Genet (2000) 0.83
Bacteremia in a general hospital. A prospective study of 102 consecutive cases. Scand J Infect Dis (1975) 0.82
Phenotypic variation in patients heterozygous for familial defective apolipoprotein B (FDB) in three European countries. Arterioscler Thromb Vasc Biol (1997) 0.82
Salmonella infections of the urinary tract. Dan Med Bull (1987) 0.82
LDL receptor mutation genotype and vascular disease phenotype in heterozygous familial hypercholesterolaemia. Clin Genet (2002) 0.81
Netilmicin: efficacy and tolerance in the treatment of systemic infections in neonates. Scand J Infect Dis Suppl (1980) 0.81
FL 1039 in bacteriuria following prostatectomy. A double-blind comparison with pivampicillin and placebo. Scand J Urol Nephrol (1974) 0.81
Sex-hormone-binding globulin deficiency. Lancet (1982) 0.81
Flow cytometric assessment of LDL receptor activity in peripheral blood mononuclear cells compared to gene mutation detection in diagnosis of heterozygous familial hypercholesterolemia. Cytometry (1999) 0.81
Aerococcus urinae: intraspecies genetic and phenotypic relatedness. Int J Syst Bacteriol (1997) 0.81
Six cases of acute appendicitis with secondary peritonitis caused by Streptococcus pneumoniae. Eur J Clin Microbiol (1984) 0.81
Treatment of urinary tract infections with a sulphamethoxazole-trimethoprim compound: a controlled, double blind, clinical trial. Scand J Infect Dis (1973) 0.80
Haemophilus isolated from unusual anatomical sites. Scand J Infect Dis (1990) 0.80
Preoperative clindamycin treatment and vaginal drainage in hysterectomy. Acta Obstet Gynecol Scand (1989) 0.80
P1A1/A2 polymorphism of platelet glycoprotein IIIa and risk of acute coronary syndromes in heterozygous familial hypercholesterolemia. Atherosclerosis (1999) 0.79
Radiofrequency ablation of atrial fibrillation: effectiveness and safety in 102 consecutive patients. Heart (2005) 0.79
Cefotaxime for prevention of infectious complications in bacteriuric men undergoing transurethral prostatic resection. A controlled comparison with methenamine. Scand J Urol Nephrol (1983) 0.79
Postmortem genetic testing of the ryanodine receptor 2 (RYR2) gene in a cohort of sudden unexplained death cases. Int J Legal Med (2012) 0.79
Urodynamic evaluation after vaginal repair and colposuspension. Br J Urol (1982) 0.78
Serum corticotrophin, plasma cortisol and urinary excretion of 17-ketogenic steroids in the elderly (age group: 66-94 years). Acta Endocrinol (Copenh) (1971) 0.78
Flow cytometry with a monoclonal antibody to the low density lipoprotein receptor compared with gene mutation detection in diagnosis of heterozygous familial hypercholesterolemia. Clin Chem (1998) 0.78
[Attitude of patients toward detection of hereditary disease. Heterozygote familial hypercholesterolemia]. Ugeskr Laeger (1998) 0.78
Two novel mutations in the LDL receptor gene: common causes of familial hypercholesterolemia in a Spanish population. Clin Genet (1996) 0.77
A frequent HhaI polymorphism in intron 9 of the low density lipoprotein receptor gene detected by the denaturing gradient gel electrophoresis technique. Clin Genet (1995) 0.77
Incomplete thromboxane inhibition with 100 mg of intravenous acetylsalicylic acid in patients with acute ST elevation myocardial infarction: a placebo-controlled pilot trial. Thromb Res (2001) 0.77
Ovarian pregnancy. Report of a case with Lippe's loop in situ. Acta Obstet Gynecol Scand (1970) 0.77
LDL-receptor gene mutations and the hypocholesterolemic response to statin therapy. Clin Genet (2001) 0.76
Characteristics of 46 heterozygous carriers and 57 unaffected relatives in five Danish families with familial defective apolipoprotein B-100. Arterioscler Thromb (1994) 0.76
Identification of a novel mutation in exon 13 of the LDL receptor gene causing familial hypercholesterolemia in two Spanish families. Biochim Biophys Acta (1996) 0.76
Molecular autopsy in young sudden cardiac death victims with suspected cardiomyopathy. Forensic Sci Int (2011) 0.76
An LDL receptor promoter mutation in a heterozygous FH patient with dramatically skewed ratio between the two allelic mRNA variants. Hum Mutat (1996) 0.76
Investigation of pituitary-adrenocortical function in the elderly during standardized operations and postoperative intravenous metyrapone test assessed by plasma cortisol, plasma compound S and eosinophil cell determinations. Acta Endocrinol (Copenh) (1971) 0.76
Flow cytometric assessment of LDL ligand function for detection of heterozygous familial defective apolipoprotein B-100. Clin Chem (2000) 0.76
Overexpression of human thymidine kinase mRNA without corresponding enzymatic activity in patients with chronic lymphatic leukemia. Leuk Res (1994) 0.75
The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction. J Intern Med (2004) 0.75
Prophylactic cavotricuspid isthmus block during atrial fibrillation ablation in patients without atrial flutter: a randomised controlled trial. Heart (2009) 0.75
Proteolysis of arterial basement membrane containing different amounts of carbohydrates. Thromb Res (1986) 0.75
[Congenital deficiency of sex hormone binding globulin]. Ugeskr Laeger (1983) 0.75
[Postmenopausal estrogen therapy. Recent aspects of parenteral administration of 17-beta estradiol]. Ugeskr Laeger (1989) 0.75
Colles' fracture treated with modified Böhler technique. Acta Orthop Scand (1971) 0.75
[Sex hormone binding globulin]. Ugeskr Laeger (1983) 0.75
[Fine-needle puncture as a diagnostic aid in gynecological tumors]. Ugeskr Laeger (1974) 0.75
[Normal values for cortisol in plasma. Determined by a double isotope derivative technic]. Ugeskr Laeger (1970) 0.75
Abnormality of the ischiopubic junction. Report of a case. Acta Orthop Scand (1969) 0.75
The possible prognostic value of serum prolactin increment during pregnancy in hyperprolactinaemic patients. Acta Endocrinol (Copenh) (1983) 0.75
[Absorption of norethisterone acetate from tablets with normal and coarse particle size]. Ugeskr Laeger (1989) 0.75
[Salmonella abscesses]. Ugeskr Laeger (1985) 0.75
[Fluconazole. A new antimycotic for systemic use]. Ugeskr Laeger (1990) 0.75
Search for circulating immune complexes and activation of the complement system in relation to estrogen treatment. Acta Obstet Gynecol Scand (1987) 0.75
[Vaginal estradiol and progesterone in climacteric therapy]. Ugeskr Laeger (1989) 0.75
[Abdominal hysterectomy in connection with conization for carcinoma in situ]. Ugeskr Laeger (1973) 0.75
[Stomach perforation at laparoscopy]. Ugeskr Laeger (1981) 0.75
Eight cases of Capnocytophaga infections in Denmark. Eur J Clin Microbiol (1986) 0.75
[Vaginismus treated by a modification of the technic of Masters and Johnson]. Ugeskr Laeger (1977) 0.75
[Fractura Collesii. Bandaging in volar flexion with a short dorsal splint]. Ugeskr Laeger (1967) 0.75
[The function of the stress axis in the postoperative phase with special regard to fatigue in elderly people]. Nord Med (1971) 0.75
The effect of treatment with oestradiol and oestriol on fasting serum cholesterol and triglyceride levels in postmenopausal women. Br J Obstet Gynaecol (1977) 0.75
[Progesterone and gestagen treatment. Pharmacologic and clinical aspects]. Ugeskr Laeger (1989) 0.75
Infections and colonisations with haemolytic streptococci group B in a Danish neonatal intensive care unit. Dan Med Bull (1984) 0.75
[Prenatal evaluation of fetal lung maturity by measuring the optical density of amniotic fluid]. Ugeskr Laeger (1984) 0.75
[Spontaneous esophageal rupture]. Ugeskr Laeger (1969) 0.75
[Changes in sexual function after hysterectomy]. Ugeskr Laeger (1982) 0.75
Spontaneous perforation of the caecum following Caesarean section. Report of a case and review of the literature. Acta Obstet Gynecol Scand (1972) 0.75
Pituitary-adrenocortical stimulation in the aged as reflected in levels of plasma cortisol and compound S. Acta Chir Scand (1970) 0.75
[Drainage of the vaginal vault as a prophylactic measure against infection after abdominal hysterectomy]. Ugeskr Laeger (1977) 0.75
[The resistance of urinary tract bacteria in hospital environment over a 4-year period. A prospective study with special reference to trimethoprim, sulfonamide and a combination of them]. Ugeskr Laeger (1985) 0.75
Pituitary-adrenal function in old age evaluated by the intravenous metyrapone test. Acta Endocrinol (Copenh) (1970) 0.75
[Renal abscess]. Ugeskr Laeger (1968) 0.75
[Urinary infection after indwelling urethral catheter following gynecological surgery]. Nord Med (1969) 0.75